13F filer · CIK 1040273 ↗

Third Point

You are looking at Q3 2022. See the latest, Q2 2026 →

Reported value

$5.53B

+31% on the quarter before

Positions

61

11 new · 8 sold out

Top 10

74.1%

of the value

Est. gain

+$333.0M

on stocks held all quarter

Est. return

+9.9%

on those stocks since Q2 2022

Filed

Nov 14, 2022

On SEC EDGAR ↗

Positions as of Sep 30, 2022, from Third Point's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

Each tile is a position, sized by its share, colored by what the fund did with it since Q2 2022. Striped tiles are options.

Colgate Palmolive Co15%
Pg&E Corp14%
Danaher Corporation13%
SentinelOne8.8%
Unitedhealth Group Inc6.1%
37 others5.2%
Bath & Body Works Inc4.8%
Twitter Inc4.4%
Ovintiv Inc3.3%
Ventyx Biosciences Inc2.7%
Eqt Corp2.4%
Walt Disney Company (The)2.4%
Dupont De Nemours Inc2.2%
Tjx Cos Inc New2.0%
Range Res Corp1.8%
Ferguson Plc New1.7%
T-Mobile Us Inc1.7%
Cano Health Inc1.7%
Hertz Global Hldgs Inc1.6%
Csx Corp1.3%
Take-Two Interactive Softwar1.0%
Pg&E Corp1.0%
Comstock Res Inc0.9%
0.8%
0.7%

Largest buys

Since Q2 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Colgate Palmolive Co~$671.9MAdded · 3.8% → 14.7%+9,565,000 shares
  2. Bath & Body Works Inc~$265.2MNew · 0.0% → 4.8%+8,135,000 shares
  3. Twitter Inc~$241.1MNew · 0.0% → 4.4%+5,500,000 shares
  4. Tjx Cos Inc New~$108.7MNew · 0.0% → 2.0%+1,750,000 shares
  5. Danaher Corporation~$103.3MAdded · 13.8% → 12.6%+400,000 shares
  6. Range Res Corp~$98.5MNew · 0.0% → 1.8%+3,900,000 shares
  7. Ferguson Plc New~$95.2MNew · 0.0% → 1.7%+925,000 shares
  8. Take-Two Interactive Softwar~$54.5MNew · 0.0% → 1.0%+500,000 shares
  9. Comstock Res Inc~$51.9MNew · 0.0% → 0.9%+3,000,000 shares
  10. Unitedhealth Group Inc~$50.5MAdded · 6.9% → 6.1%+100,000 shares

Largest sells

Since Q2 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Eqt Corp~$174.2MCut · 6.1% → 2.4%−4,275,000 shares
  2. Cenovus Energy Inc~$138.3MSold out · 3.3% → 0.0%−7,275,000 shares
  3. Antero Resources Corp~$100.5MCut · 2.5% → 0.1%−3,292,891 shares
  4. Ovintiv Inc~$97.5MCut · 6.4% → 3.3%−2,120,000 shares
  5. Crown Hldgs Inc~$73.7MSold out · 1.7% → 0.0%−800,000 shares
  6. Csx Corp~$59.0MCut · 3.4% → 1.3%−2,215,000 shares
  7. Archaea Energy Inc~$53.8MSold out · 1.3% → 0.0%−3,465,000 shares
  8. SentinelOne~$53.1MCut · 11.6% → 8.8%−2,078,846 shares
  9. Dupont De Nemours Inc~$35.5MCut · 4.1% → 2.2%−705,000 shares
  10. Go Acquisition Corp~$29.9MSold out · 0.7% → 0.0%−3,000,000 shares

Holdings

As of Sep 30, 2022. Changes are in shares against Jun 30, 2022, so a price move alone never reads as a buy or a sale.

Positions, sorted by share of the portfolio
HoldingValue
Colgate Palmolive CoCOM · shares +482% · price −12.3%14.7%$811.4M−$19.6M
Pg&E CorpCOM · shares −3.1% · price +25.3%14.3%$792.5M+$159.8M
Danaher CorporationCOM · shares +17% · price +1.9%12.6%$697.4M+$11.0M
SentinelOneCL A · shares −9.9% · price +9.6%8.8%$485.6M+$42.4M
Unitedhealth Group IncCOM · shares +18% · price −1.7%6.1%$338.4M−$4.9M
Bath & Body Works IncCOM · shares New4.8%$265.2M—
Twitter IncCOM · shares New4.4%$241.1M—
Ovintiv IncCOM · shares −35% · price +4.1%3.3%$184.0M+$7.2M
Ventyx Biosciences IncCOM · shares 0% · price +185.4%2.7%$150.6M+$97.8M
Eqt CorpCOM · shares −57% · price +18.5%2.4%$132.4M+$20.6M
Walt Disney Company (The)COM · shares +40% · price −0.1%2.4%$132.1M−$70,000
Dupont De Nemours IncCOM · shares −23% · price −9.3%2.2%$119.7M−$12.3M
Tjx Cos Inc NewCOM · shares New2.0%$108.7M—
Range Res CorpCOM · shares New1.8%$98.5M—
Ferguson Plc NewSHS · shares New1.7%$95.2M—
T-Mobile Us IncCOM · shares +44% · price −0.3%1.7%$93.9M−$179,550
Cano Health IncCOM CL A · shares 0% · price +97.9%1.7%$93.9M+$46.4M
Hertz Global Hldgs IncCOM NEW · shares −15% · price +2.8%1.6%$87.1M+$2.4M
Csx CorpCOM · shares −45% · price −8.3%1.3%$73.3M−$6.7M
Take-Two Interactive SoftwarCOM · shares New0.98%$54.5M—
Pg&E CorpUNIT 08/16/2023 · shares 0% · price +19.5%0.97%$53.8M+$8.8M
Comstock Res IncCOM · shares New0.94%$51.9M—
Perimeter Solutions SaCOMMON STOCK · shares −1.7% · price −26.1%0.83%$46.1M−$16.3M
Jaws Mustang Acquisition CorSHS CL A · shares 0% · price +1.1%0.72%$39.8M+$440,000
Global Blue Group Holding AgORD SHS · shares 0% · price −5.9%0.71%$39.5M−$2.5M
Total · 61 positions100%$5.53B+$333.0M

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q2 2022 to Q3 2022: 50 stocks held throughout, up $333.0M (+9.9%).

  1. Pg&E Corp+$159.8M+25%
  2. Ventyx Biosciences Inc+$97.8M+185%
  3. Cano Health Inc+$46.4M+98%
  4. SentinelOne+$42.4M+10%
  5. Eqt Corp+$20.6M+18%
  6. Unitedhealth Group Inc−$4.9M−2%
  7. Csx Corp−$6.7M−8%
  8. Dupont De Nemours Inc−$12.3M−9%
  9. Perimeter Solutions Sa−$16.3M−26%
  10. Colgate Palmolive Co−$19.6M−12%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.

Reported value by quarter

The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.

$20.00B$10.00B$0
Q1 2016Q2 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q2 2026$4.68B+125%SEC ↗
Q1 2026$2.08B−71%SEC ↗
Q4 2025$7.27B−19%SEC ↗
Q3 2025$8.99B+18%SEC ↗
Q2 2025$7.62B+16%SEC ↗
Q1 2025$6.55B−12%SEC ↗
Q4 2024$7.44B+0%SEC ↗
Q3 2024$7.43B−15%SEC ↗
Q2 2024$8.74B+11%SEC ↗
Q1 2024$7.85B+18%SEC ↗
Q4 2023$6.64B+1%SEC ↗
Q3 2023$6.59B−3%SEC ↗
Q2 2023$6.82B+12%SEC ↗
Q1 2023$6.11B+2%SEC ↗
Q4 2022$5.97B+8%SEC ↗
Q3 2022$5.53B+31%SEC ↗
Q2 2022$4.22B−45%SEC ↗
Q1 2022$7.68B−46%SEC ↗
Q4 2021$14.33B−22%SEC ↗
Q3 2021$18.32B+7%SEC ↗
Q2 2021$17.08B+15%SEC ↗
Q1 2021$14.84B+14%SEC ↗
Q4 2020$12.97B+30%SEC ↗
Q3 2020$10.00B+37%SEC ↗
Q2 2020$7.30B+17%SEC ↗
Q1 2020$6.27B−28%SEC ↗
Q4 2019$8.70B+3%SEC ↗
Q3 2019$8.42B−1%SEC ↗
Q2 2019$8.54B−5%SEC ↗
Q1 2019$8.99B+38%SEC ↗
Q4 2018$6.51B−55%SEC ↗
Q3 2018$14.31B−0%SEC ↗
Q2 2018$14.35B+8%SEC ↗
Q1 2018$13.32B−4%SEC ↗
Q4 2017$13.86B+16%SEC ↗
Q3 2017$11.90B+5%SEC ↗
Q2 2017$11.28B+10%SEC ↗
Q1 2017$10.25B+1%SEC ↗
Q4 2016$10.19B−11%SEC ↗
Q3 2016$11.50B+10%SEC ↗
Q2 2016$10.49B−3%SEC ↗
Q1 2016$10.86BSEC ↗

Get the newsletter

The day's AI and market news, in your inbox every weekday.